Toxicological and Environmental Emergency Presentations

#inProgress

ME 3.8.1.1

Aetiology and pathophysiology of poisoning, drug overdose and envenomation.

ME 3.8.1.2

Aetiology and pathophysiology of hyperthermia and hypothermia

ME 3.8.1.3
ME 3.8.1.4(a)

Principles of assessment of toxicological presentations in the ED, including: Triage and initial assessment

ME 3.8.1.4(b)

Principles of assessment of toxicological presentations in the ED, including: General approach to assessment

ME 3.8.1.4(c)

Principles of assessment of toxicological presentations in the ED, including: Risk assessment

ME 3.8.1.4(d)

Principles of assessment of toxicological presentations in the ED, including: History (dose, drug, timing, symptoms, patient factors)

ME 3.8.1.4(e)

Principles of assessment of toxicological presentations in the ED, including: Examination

ME 3.8.1.4(f)

Principles of assessment of toxicological presentations in the ED, including: Investigations (ECG: sodium channel blockade, QT prolongation)

ME 3.8.1.4(g)

Principles of assessment of toxicological presentations in the ED, including: Role of toxicologists

ME 3.8.1.4(h)

Principles of assessment of toxicological presentations in the ED, including: Common presentations (e.g. paracetamol, quetiapine, SSRI)

ME 3.8.1.5(a)

Principles of assessment of environmental presentations in the ED, including: Triage and initial assessment

ME 3.8.1.5(b)

Principles of assessment of environmental presentations in the ED, including: General approach to assessment

ME 3.8.1.5(c)

Principles of assessment of environmental presentations in the ED, including: Risk assessment

ME 3.8.1.5(d)

Principles of assessment of environmental presentations in the ED, including: History

ME 3.8.1.5(e)

Principles of assessment of environmental presentations in the ED, including: Examination

ME 3.8.1.5(f)

Principles of assessment of environmental presentations in the ED, including: Investigations

ME 3.8.1.6(a)

Principles of management of toxicological presentations including: Prehospital care

ME 3.8.1.6(b)

Principles of management of toxicological presentations including: General approach to management

ME 3.8.1.6(c)

Principles of management of toxicological presentations including: Indications for decontamination

ME 3.8.1.6(d)

Principles of management of toxicological presentations including: Indications for enhanced elimination

ME 3.8.1.6(e)

Principles of management of toxicological presentations including: Indications for antidotes

ME 3.8.1.7

Principles of management of environmental presentations including:

ME 3.8.1.13

Role of poison centres in the management and prevention of poisoning.

ME 3.8.1.14

Principles of chemical dependency and substance abuse, including drug tolerance and drug withdrawal.

ME 3.8.1.15

Take a history, perform a targeted examination and risk assessment of a poisoned patient, including agent, dose, time of ingestion, clinical features and patient factors.

ME 3.8.1.16

Interpret symptoms and clinical signs of poisoning.

ME 3.8.1.17

Identify the underlying cause of the presentation, including distinguishing toxidromes for poisoning, drug overdose and envenomation.

ME 3.8.1.18

Safely and appropriately apply pressure immobilization bandage, including use of splinting.

ME 3.8.2.1(a)

Medicolegal considerations in the assessment and management of toxicological presentations, including: Use of restraints, physical and chemical

ME 3.8.2.1(b)

Medicolegal considerations in the assessment and management of toxicological presentations, including: Transport of the patient under a section or treatment order

ME 3.8.2.1(c)

Medicolegal considerations in the assessment and management of toxicological presentations, including: Paediatric patients

ME 3.8.2.1(d)

Medicolegal considerations in the assessment and management of toxicological presentations, including: Management of patient escorts

ME 3.8.2.2

Psychiatric and social aspects of overdose.

ME 3.8.2.3(a)

Principles of assessment and management of toxicological presentations in the ED, including: Paediatric patients presenting with suspected ingestion of toxic substances or items, including batteries

ME 3.8.2.3(b)

Principles of assessment and management of toxicological presentations in the ED, including: Drugs of abuse (stimulants, opioids, sedatives [eg GHB, benzodiazepines]) and withdrawal

ME 3.8.2.4

Identify the appropriate antidote or antivenom.

ME 3.8.2.5

Identify patients requiring decontamination.

ME 3.8.2.6
ME 3.8.2.7

Identify patients requiring warming or cooling, and initiate basic warming and cooling techniques, including external methods and administration of IV fluids.

ME 3.8.2.8

Provide appropriate treatment for a toxicological presentation.

ME 3.8.3.1(a)

Principles of assessment and management of toxicological presentations in the ED, including: Life threatening presentations (e.g., calcium channel blockers, beta blockers, TCA, toxic alcohols)

ME 3.8.3.1(b)

Principles of assessment and management of toxicological presentations in the ED, including: Envenomation (snake, spider, marine)

ME 3.8.3.1(c)

Principles of assessment and management of toxicological presentations in the ED, including: Poisonous fungi and plants (ingestion, exposure)

ME 3.8.3.2(a)

Principles of industrial toxicology, including presentations associated with exposure to and/or ingestion of: Toxic metals and metal fumes

ME 3.8.3.2(b)

Principles of industrial toxicology, including presentations associated with exposure to and/or ingestion of: Toxic gases

ME 3.8.3.2(c)

Principles of industrial toxicology, including presentations associated with exposure to and/or ingestion of: Toxic liquids

ME 3.8.3.2(d)

Principles of industrial toxicology, including presentations associated with exposure to and/or ingestion of: Pesticides, herbicides and rodenticides

ME 3.8.3.3(a)

Aetiology and pathophysiology of exposure syndromes of chemical, biological and radiological agents, with specific regard to: Dose-response relationships and factors affecting toxicity

ME 3.8.3.3(b)

Aetiology and pathophysiology of exposure syndromes of chemical, biological and radiological agents, with specific regard to: Latency

ME 3.8.3.4

Sources of toxin and chemical, biological and radiological agent advice.

ME 3.8.3.5(a)

Lead a team to resuscitate a patient with: Toxicological presentation

ME 3.8.3.5(b)

Lead a team to resuscitate a patient with: Hypothermia or hyperthermia, using advanced warming and cooling techniques.

ME 3.8.3.5(c)

Lead a team to resuscitate a patient with: Decompression illness

ME 3.8.3.6

Initiate specific decontamination measures, including gastric decontamination and whole bowel irrigation.

ME 3.8.3.7

Appropriately package the patient for transport as required.